These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14668796)

  • 21. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
    Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS
    Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice.
    Kosanke S; Edgerton SM; Moore D; Yang X; Mason T; Alvarez K; Jones L; Kim A; Thor AD
    Comp Med; 2004 Jun; 54(3):280-7. PubMed ID: 15253274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L; Xiang B; Muthuswamy SK
    Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues.
    Marozkina NV; Stiefel SM; Frierson HF; Parsons SJ
    J Cell Biochem; 2008 Apr; 103(6):2010-8. PubMed ID: 17960555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network.
    Morandell S; Stasyk T; Skvortsov S; Ascher S; Huber LA
    Proteomics; 2008 Nov; 8(21):4383-401. PubMed ID: 18846509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
    Taverna D; Crowley D; Connolly M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(22):10324-9. PubMed ID: 16288021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS; Kapitonov D; O'Rourke DM
    Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
    Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G
    Cancer Res; 2000 Jan; 60(2):359-64. PubMed ID: 10667588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
    Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
    Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
    Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
    Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of Muc1 in MMTV-c-Neu tumors.
    Adriance MC; Gendler SJ
    Oncogene; 2004 Jan; 23(3):697-705. PubMed ID: 14737104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-opted integrin signaling in ErbB2-induced mammary tumor progression.
    Carraway KL; Sweeney C
    Cancer Cell; 2006 Aug; 10(2):93-5. PubMed ID: 16904607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic determinants of malignancy in a mouse model for oligodendroglioma.
    Weiss WA; Burns MJ; Hackett C; Aldape K; Hill JR; Kuriyama H; Kuriyama N; Milshteyn N; Roberts T; Wendland MF; DePinho R; Israel MA
    Cancer Res; 2003 Apr; 63(7):1589-95. PubMed ID: 12670909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of a variety of preneoplasias and tumours in the mammary glands of transgenic rats.
    Davies BR; Warren JR; Schmidt G; Rudland PS
    Biochem Soc Symp; 1998; 63():167-84. PubMed ID: 9513721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of proviral sequences, but not at the common integration sites of the FGF8 locus, in an androgen-dependent mouse mammary Shionogi carcinoma.
    Kuriki K; Kamiakito T; Yoshida H; Saito K; Fukayama M; Tanaka A
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1147-56. PubMed ID: 11075944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
    Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.